Innovative medications are worthless if people can't afford them.
John Sarbanes: “Innovative medications are worthless if people can't afford them.”
Editor's note · Context
Emphasizing the importance of affordability in medication despite claims of innovation by drug manufacturers.
Share
More from John Sarbanes
I hope that today's hearing is the first step in continuing that legacy of strong bipartisan support for the Chesapeake Bay in this Congress.
This bill takes important steps to support the ongoing restoration of the Chesapeake Bay by reauthorizing NOAA's Chesapeake Bay Office and authorizing the agency's long-running Bay Watershed Education and Training, or B-WET Grant program.
Congress gave EPA this role more than 50 years ago under the Clean Air Act and reaffirmed that responsibility in 2005 under the Energy Policy Act.
It's a national environmental treasure. It's a regional economic engine. It's been one of my top priorities since I've come to Congress.





